pyrrolidonecarboxylic acid

Preferred Label : pyrrolidonecarboxylic acid;

MeSH definition : A cyclized derivative of L-GLUTAMIC ACID. Elevated blood levels may be associated with problems of GLUTAMINE or GLUTATHIONE metabolism.;

MeSH synonym : 5-oxopyrrolidine-2-carboxylic acid; 5-ketoproline; 5-oxoproline; pidolic acid; pyroglutamic acid;

CISMeF synonym : acid, pyroglutamic; acid, pyrrolidonecarboxylic;

MeSH hyponym : pyroglutamate; magnesium pidolate; Pidolate, Magnesium;

MeSH CAS label : L-Proline, 5-oxo-;

MeSH Related Number : 98-79-3 (Pyrrolidonecarboxylic acid); magnesium pidolate; pyroglutamate; V5PC588N7G;

Registry Number MeSH : 98-79-3;

Related CAS MeSH : V5PC588N7G (Magnesium pidolate); SZB83O1W42 (Pyroglutamate);

Wikipedia link : https://en.wikipedia.org/wiki/Pyroglutamic acid;

Codes EINECS : 202-700-3;

Is substance : O;

UNII : SZB83O1W42;

InChIKey : ODHCTXKNWHHXJC-VKHMYHEASA-N;

Details

Origin ID

D011761;

UMLS CUI

C0034330;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- pidolic acid [Substance BNPC]
Currated CISMeF NLP mapping
- 5-Oxoproline [LOINC component]
- Magnesium pidolate [ICD-11 Extension code]
- Pidolic Acid [NCIt concept]
- Pidolic acid [SMS substance]
- Pyroglutamic acid (substance) [SNOMED CT concept]
Record concept(s)
- magnesium pidolate [MeSH concept]
- pyroglutamate [MeSH concept]
- pyrrolidonecarboxylic acid [MeSH concept]
Related MeSH Supplementary Concept(s)
- (S)-ethyl 4,4-dimethyl pyroglutamate [MeSH Supplementary Concept]
- 125I-labeled heptapeptide(2-8)-leucopyrokinin [MeSH Supplementary Concept]
- 2,3-methanopyroglutamic acid [MeSH Supplementary Concept]
- 2,4-dihydroxy-3,3,4-trimethylpyroglutamic acid [MeSH Supplementary Concept]
- 2-deoxy-2-(2-fluoro-3-hydroxytetradecanamido)-3-O-(3-hydroxytetradecanoyl)-4-O-phosphonoglucopyranose [MeSH Supplementary Concept]
- 2-oxothiazolidine-4-carboxylic acid [MeSH Supplementary Concept]
- 3-(3-hydroxy-2,3-dimethyl-5-oxoprolyl)amino-3-6-dideoxyglucose [MeSH Supplementary Concept]
- 3-(4-methoxy-3-methyl-2-oxo-2H-pyran-6-yl)butylpyroglutamate [MeSH Supplementary Concept]
- 3-hydroxy-3-isobutyl-2-pyrrolidone-5-carboxylic acid [MeSH Supplementary Concept]
- 4-aminopyroglutamate [MeSH Supplementary Concept]
- 4-pyroglutamyl-glycyl-arginyl-phenylalaninamide [MeSH Supplementary Concept]
- 9-fluoroenylmethoxycarbonylpyroglutamate [MeSH Supplementary Concept]
- Antho-RWamide I [MeSH Supplementary Concept]
- BAM 1745 [MeSH Supplementary Concept]
- BLAS 236 [MeSH Supplementary Concept]
- DAKH peptide [MeSH Supplementary Concept]
- FR 900148 [MeSH Supplementary Concept]
- GPAnt-2 [MeSH Supplementary Concept]
- L-pyroglutamyl-L-alanine [MeSH Supplementary Concept]
- L-pyroglutamyl-L-histidyl-3,3-dimethylprolinamide [MeSH Supplementary Concept]
- LHRH cysteamide, des-Arg- [MeSH Supplementary Concept]
- LHRH, Gln(8)- [MeSH Supplementary Concept]
- LHRH, Lys(6)-N-Et-ProNH2(9)- [MeSH Supplementary Concept]
- LHRH, pGlu(1)-4-Cl-Phe(2)-Trp(3,6)- [MeSH Supplementary Concept]
- LHRH, pGlu(1)-Phe(2)-Trp(3)-Lys(6)- [MeSH Supplementary Concept]
- LHRH, pGlu(1)-Phe(2)-Trp(3)-Ser(4)-N-epsilon-azidobenzoyl-Lys(6)- [MeSH Supplementary Concept]
- LHRH, pGlu(1)-Phe(2)-Trp(3,6)- [MeSH Supplementary Concept]
- Led-CC-I peptide [MeSH Supplementary Concept]
- Led-CC-II peptide [MeSH Supplementary Concept]
- N(I),N(II),N(III),N(IV)-tetraacetyl-NV-dimethylaminophenylazophenylthioureido-beta-chitopentaosyl-pyroglutamyl amidoethylnaphthalenesulfonic acid [MeSH Supplementary Concept]
- N-(2-chloro-3-(trifluoromethyl)benzyl)-N-methyl-5-oxopyrrolidine-2-carboxamide [MeSH Supplementary Concept]
- N-alpha-carbobenzoxypyroglutamic acid chloromethyl ketone [MeSH Supplementary Concept]
- N-hydroxymethylpyrrolidonecarboxylic acid [MeSH Supplementary Concept]
- NC 1900 [MeSH Supplementary Concept]
- OptoGluNAM4.1 [MeSH Supplementary Concept]
- PG-KII peptide [MeSH Supplementary Concept]
- S 2366 [MeSH Supplementary Concept]
- S 2484 [MeSH Supplementary Concept]
- SK&F 108636 [MeSH Supplementary Concept]
- Tem-HrTH [MeSH Supplementary Concept]
- adipokinetic hormone [MeSH Supplementary Concept]
- adipokinetic hormone, beetle [MeSH Supplementary Concept]
- adipokinetic hormone, magicicada [MeSH Supplementary Concept]
- adipokinetic hormone, tabanus atratus [MeSH Supplementary Concept]
- amphetamine, pGlu-His- [MeSH Supplementary Concept]
- arginylpyroglutamate [MeSH Supplementary Concept]
- argipressin (4-9), (3-1')-disulfide Cys(6)- [MeSH Supplementary Concept]
- blomhotin [MeSH Supplementary Concept]
- calcium pidolate [MeSH Supplementary Concept]
- cardioacceleratory peptide 2b [MeSH Supplementary Concept]
- delta-(spiro-4-hydroxy-2,5-cyclohexadienyl)pyroglutamate [MeSH Supplementary Concept]
- dodecyl pyroglutamate [MeSH Supplementary Concept]
- eisenin [MeSH Supplementary Concept]
- epidermal pentapeptide [MeSH Supplementary Concept]
- ethyl 1-benzyl-3-hydroxy-2(5H)-oxopyrrole-4-carboxylate [MeSH Supplementary Concept]
- ethyl N-methyl-4-hydroxy-5-oxo-3-pyrroline-3-carboxylate iron chelate [MeSH Supplementary Concept]
- gamma-(pyroglutamyl-glutamyl-asparaginyl-glycine)amide [MeSH Supplementary Concept]
- glucagon-like peptide-1 (7-36)amide, N-pyroglutamyl- [MeSH Supplementary Concept]
- glutaminyl-pyroglutamyl-glutamyl-proline amide [MeSH Supplementary Concept]
- gonadotropin-releasing hormone-III [MeSH Supplementary Concept]
- head activator peptide [MeSH Supplementary Concept]
- hemoregulatory peptide 5b [MeSH Supplementary Concept]
- hypotrehalosemic hormone, tabanus atratus [MeSH Supplementary Concept]
- lamprey GnRH-I [MeSH Supplementary Concept]
- leucopyrokinin [MeSH Supplementary Concept]
- leucosulfakinin II [MeSH Supplementary Concept]
- locustapyrokinin II [MeSH Supplementary Concept]
- metadoxine [MeSH Supplementary Concept]
- metamorphosin A [MeSH Supplementary Concept]
- methyl pyroglutamyl-histidyl-pipecolate [MeSH Supplementary Concept]
- neurotensin (1-10) [MeSH Supplementary Concept]
- neurotensin (1-8) [MeSH Supplementary Concept]
- oleyl pyroglutamate [MeSH Supplementary Concept]
- pGlu-His-Pro-amphetamine [MeSH Supplementary Concept]
- phyllolitorin [MeSH Supplementary Concept]
- phyllolitorin, Leu-8- [MeSH Supplementary Concept]
- phyllolitorin, des-Trp-3,Leu-8- [MeSH Supplementary Concept]
- pidotimod [MeSH Supplementary Concept]
- pirglutargina [MeSH Supplementary Concept]
- pro-thyrotropin releasing hormone [MeSH Supplementary Concept]
- protirelin, Nle(2)-Prot(3)- [MeSH Supplementary Concept]
- pyro-gamma-carboxyglutamic acid [MeSH Supplementary Concept]
- pyroglutamic acid 7-amino-4-methylcoumarin [MeSH Supplementary Concept]
- pyroglutamic acid chloromethyl ketone [MeSH Supplementary Concept]
- pyroglutamine-4-nitroanilide [MeSH Supplementary Concept]
- pyroglutaminyl-seryl-leucinamide [MeSH Supplementary Concept]
- pyroglutamyl diazomethyl ketone [MeSH Supplementary Concept]
- pyroglutamyl-((N3)-imidazolylmethyl)-histidyl-n-amylprolinamide [MeSH Supplementary Concept]
- pyroglutamyl-3-methylhistidyl-glycine [MeSH Supplementary Concept]
- pyroglutamyl-L-DOPA-proline [MeSH Supplementary Concept]
- pyroglutamyl-L-histidyl-L-pipecolic acid amide [MeSH Supplementary Concept]
- pyroglutamyl-alanyl-glutamyl-seryl-asparagine [MeSH Supplementary Concept]
- pyroglutamyl-alanyl-tyrosine [MeSH Supplementary Concept]
- pyroglutamyl-asparaginamide [MeSH Supplementary Concept]
- pyroglutamyl-asparagyl-tryptophan [MeSH Supplementary Concept]
- pyroglutamyl-aspartyl-prolyl-phenylalanyl-leucyl-arginyl-phenylalaninamide [MeSH Supplementary Concept]
- pyroglutamyl-glutaminyl-glycyl-seryl-asparagine [MeSH Supplementary Concept]
- pyroglutamyl-glutaminyl-tryptophan [MeSH Supplementary Concept]
- pyroglutamyl-glutamyl-asparaginyl-glycine [MeSH Supplementary Concept]
- pyroglutamyl-glutamyl-glycyl-seryl-asparagine [MeSH Supplementary Concept]
- pyroglutamyl-glutamyl-proline amide [MeSH Supplementary Concept]
- pyroglutamyl-histidyl-3-methylprolinamide [MeSH Supplementary Concept]
- pyroglutamyl-histidyl-alanine [MeSH Supplementary Concept]
- pyroglutamyl-histidyl-glycine [MeSH Supplementary Concept]
- pyroglutamyl-histidyl-proline thioamide [MeSH Supplementary Concept]
- pyroglutamyl-histidyl-proline-tyramine [MeSH Supplementary Concept]
- pyroglutamyl-histidyl-prolyl-2-naphthylamide [MeSH Supplementary Concept]
- pyroglutamyl-histidyl-tryptophyl--seryl-tyrosyl-tryptophyl-leucyl-arginyl-prolyl-glycinamide [MeSH Supplementary Concept]
- pyroglutamyl-histidyl-tryptophyl-seryl-tyrosyl methyl ester [MeSH Supplementary Concept]
- pyroglutamyl-leucyl-asparaginyl-phenylalanyl-seryl-threonyl-glycyl-tryptophanamide [MeSH Supplementary Concept]
- pyroglutamyl-leucyl-glycyl-arginyl-phenylalaninamide [MeSH Supplementary Concept]
- pyroglutamyl-leucyl-prolinamide [MeSH Supplementary Concept]
- pyroglutamyl-leucyl-threonyl-phenylalanyl-threonyl-prolyl-asparaginyl-tryptophyl-glycyl-serinamide [MeSH Supplementary Concept]
- pyroglutamyl-leucyl-tryptophan methyl ester [MeSH Supplementary Concept]
- pyroglutamyl-lysyl-serine [MeSH Supplementary Concept]
- pyroglutamyl-lysyl-tryptophan [MeSH Supplementary Concept]
- pyroglutamyl-naphthylamide [MeSH Supplementary Concept]
- pyroglutamyl-peptidase II [MeSH Supplementary Concept]
- pyroglutamyl-phenylalanyl-glycine [MeSH Supplementary Concept]
- pyroglutamyl-phenylalanyl-leucine-4-nitroanilide [MeSH Supplementary Concept]
- pyroglutamyl-phenylalanyl-phenylalanyl-alanyl-leucyl-methioninamide [MeSH Supplementary Concept]
- pyroglutamyl-phenylalanyl-prolinamide [MeSH Supplementary Concept]
- pyroglutamyl-phenylalanyl-prolyl-N-methyl-psi(5-tetrazole) [MeSH Supplementary Concept]
- pyroglutamyl-prolyl-asparaginyl-prolyl-aspartyl-glutamyl-phenylalanyl-phenylalanyl-glycyl-leucyl-methioninamide [MeSH Supplementary Concept]
- pyroglutamyl-seryl-glycinamide [MeSH Supplementary Concept]
- pyroglutamyl-seryl-phenylalanine amide [MeSH Supplementary Concept]
- pyroglutamyl-tryptophyl-leucyl-lysyl-glycyl-arginyl-phenylalaninamide [MeSH Supplementary Concept]
- pyroglutamyl-tyrosyl-prolinamide [MeSH Supplementary Concept]
- pyroglutamyl-tyrosyl-prolylamide [MeSH Supplementary Concept]
- pyroglutamylalanine amide [MeSH Supplementary Concept]
- pyroglutamylasparagine diketopiperazine [MeSH Supplementary Concept]
- pyroglutamylbenzylamide [MeSH Supplementary Concept]
- pyroglutamylglutamine diketopiperazine [MeSH Supplementary Concept]
- pyroglutamylglycine [MeSH Supplementary Concept]
- pyroglutamylhistidine [MeSH Supplementary Concept]
- pyroglutamylhistidyl-N-ethylamide [MeSH Supplementary Concept]
- pyroglutamylleucine [MeSH Supplementary Concept]
- pyroglutamyltryptophan [MeSH Supplementary Concept]
- pyroglutamylvaline [MeSH Supplementary Concept]
- ranatensin [MeSH Supplementary Concept]
- red pigment-concentrating hormone [MeSH Supplementary Concept]
- rohdei-litorin [MeSH Supplementary Concept]
- septide [MeSH Supplementary Concept]
- sincalide, pGlu- [MeSH Supplementary Concept]
- substance P (5-11), Glp(5)-Glu(O-benzyl)(11)- [MeSH Supplementary Concept]
- substance P (5-11), pGlu(5)-MePhe(8)-MeGly(9)- [MeSH Supplementary Concept]
- substance P (6-11) [MeSH Supplementary Concept]
- substance P (6-11), Glp(6)-Glu(O-benzyl)(11)- [MeSH Supplementary Concept]
- substance P (6-11), Glp(6)-iodo-Tyr(8)- [MeSH Supplementary Concept]
- substance P (6-11), pGlu(6)- [MeSH Supplementary Concept]
- substance P (6-11), pGlu(6)-N-MeLeu(10)- [MeSH Supplementary Concept]
- substance P (6-11), pGlu(6)-N-MePhe(7)- [MeSH Supplementary Concept]
- substance P (6-11), pGlu(6)-N-MePhe(8)-Aib(9)- [MeSH Supplementary Concept]
- substance P (6-11), pGlu(6)-Phe(8)-psi-(methyleneoxy)-Gly(9)- [MeSH Supplementary Concept]
- substance P, pGlu(5)-MePhe(8)-Sar(9)- [MeSH Supplementary Concept]
- thyrotropin-releasing hormone, 1-Me- [MeSH Supplementary Concept]
- thyrotropin-releasing hormone, 2-diazohistidinyl- [MeSH Supplementary Concept]
- thyrotropin-releasing hormone, 3-Me- [MeSH Supplementary Concept]
- thyrotropin-releasing hormone, Gly-Lys-Arg- [MeSH Supplementary Concept]
- thyrotropin-releasing hormone, deamido- [MeSH Supplementary Concept]
- thyrotropin-releasing hormone, gly [MeSH Supplementary Concept]
- thyrotropin-releasing hormone, linear beta-Ala- [MeSH Supplementary Concept]
- wy 43657 [MeSH Supplementary Concept]
See also (suggested by CISMeF)
- 5-oxoprolinase deficiency [MeSH Supplementary Concept]
- glutathione synthetase deficiency [MeSH Supplementary Concept]
- glutathione synthetase deficiency [MeSH Supplementary Concept]
See also inter- (CISMeF)
- magnesium pidolate [ATC Code]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Biologically Active Substance [UMLS semantic type]
- Indicator, Reagent, or Diagnostic Aid [UMLS semantic type]
UMLS correspondences (same concept)
- 5-Oxoproline [LOINC component]
- Pidolic Acid [NCIt concept]
- Pyroglutamic acid (substance) [SNOMED CT concept]
- pidolic acid [Substance BNPC]
Validated automatic mappings to BTNT
- Magnesium pidolate [SMS substance]
- Magnesium pidolate (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients